4 April 2025
Reach plc
(the Company)
Purchase of Shares for the Employee Benefit Trust
The Company has been notified by the Trustee of the Reach Employee Benefit Trust (EBT) that the EBT has purchased a total of 414,174 Ordinary Shares of 10p each in the Company. Further detail is set out below.
This purchase is in line with the position confirmed to shareholders at the 2024 AGM that the Company intends to buy shares into the EBT when it is appropriate to do so to aid the management of overall dilution from share plans.
| Date | Exchange | Number of shares | Price per share (pence) |
| 2 April 2025 | XLON | 275,000 | 72.2 |
| 3 April 2025 | XLON | 139,174 | 71.3947 |
The average price of the above purchases was 71.79735 pence per share.
The shares will be held in the EBT, which is a discretionary trust for the benefit of the Group's employees. The shares will be used to satisfy the exercise of share options by employees or the release of restricted shares, including to Persons Discharging Managerial Responsibility (PDMRs) of the Company.
Further to this purchase, the EBT holds a total of 2,743,291 Ordinary Shares which represents 0.86% of the Company's issued share capital. The total number of Ordinary Shares of 10p each in issue (excluding treasury shares) is 318,157,956.
The Company will continue to keep this under review, and will look to make further purchases into the EBT when it is appropriate to do so.
| Enquiries |
|
|
|
|
| Reach plc
|
|
| Piers North, Chief Executive Officer Darren Fisher, Chief Financial Officer Laura Harris, Group Company Secretary
| 020 7293 3000 |
| Teneo
|
|
| Giles Kernick | 020 7353 4200 |
LEI: 213800GNI5XF3XOATR61
Classification: 3.1 Additional regulated information required to be disclosed under the laws of the United Kingdom
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.